SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-24-015774
Filing Date
2024-03-28
Accepted
2024-03-27 21:00:30
Documents
6
Effectiveness Date
2024-03-28

Document Format Files

Seq Description Document Type Size
1 S-8 ef20025363_s8.htm S-8 44493
2 EXHIBIT 5.1 ef20025363_ex5-1.htm EX-5.1 9587
3 EXHIBIT 23.1 ef20025363_ex23-1.htm EX-23.1 2014
4 EXHIBIT 107.1 ef20025363_ex107-1.htm EX-FILING FEES 13517
5 image00003.jpg GRAPHIC 2533
6 image51.jpg GRAPHIC 2968
  Complete submission text file 0001140361-24-015774.txt   78663
Mailing Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130
Business Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130 (619) 949-3681
GYRE THERAPEUTICS, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278291 | Film No.: 24793097
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)